MicroRNA-379-5p plays a tumor-suppressive role in human bladder cancer growth and metastasis by directly targeting MDM2 Corrigendum in /10.3892/or.2022.8413

Wu,Deyao; Niu,Xiaobing; Tao,Jun; Li,Pengchao; Lu,Qiang; Xu,Aiming; Chen,Wei; Wang,Zengjun

doi:10.3892/or.2017.5607

MicroRNA-379-5p plays a tumor-suppressive role in human bladder cancer growth and metastasis by directly targeting MDM2

Corrigendum in: /10.3892/or.2022.8413

Authors:
- Deyao Wu
- Xiaobing Niu
- Jun Tao
- Pengchao Li
- Qiang Lu
- Aiming Xu
- Wei Chen
- Zengjun Wang
View Affiliations

Affiliations: State Key Laboratory of Reproductive Medicine and Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, P.R. China
Published online on: April 27, 2017 https://doi.org/10.3892/or.2017.5607
Pages: 3502-3508

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Bladder cancer is the second most common urological malignancy in the US and is the most frequently diagnosed urological malignancy in China. An increasing amount of evidence indicates that microRNAs perform extremely important functions in many biological processes related to the formation and progression of cancers, including bladder cancer. Previous studies have reported that microRNA‑379-5p (miR-379-5p) is involved in tumour initiation and development in human cancers. However, the expression pattern, biological functions and the underlying mechanisms of miR-379-5p in bladder cancer remain unknown. The present study demonstrated that the expression levels of miR‑379-5p in bladder cancer tissues and cell lines were lower than the levels in adjacent normal tissues and the human bladder epithelial immortalized SV-HUC-1 cell line. Restoration of the expression of miR-379-5p inhibited bladder cancer cell proliferation, migration and invasion. Mouse double minute 2 (MDM2) was identified as a direct target gene of miR-379-5p. Furthermore, similar to miR-379-5p overexpression in bladder cancer cells, inhibition of MDM2 exerted tumor-suppressive effects. Rescue experiments showed that upregulation of MDM2 reversed the inhibitory effects of miR-379-5p on bladder cancer cell proliferation, migration and invasion. MDM2 was highly expressed and inversely correlated with miR-379-5p expression in bladder cancer tissues. These findings suggest that the miR-379-5p/MDM2 pathway plays an important role in bladder cancer and could serve as a potential candidate for bladder cancer therapeutics.

View Figures

View References

1	Zhang Y, Sun Y, Chen T, Hu H, Xie W, Qiao Z, Ding N, Xie L, Li S, Wang W, et al: Genetic variations rs11892031 and rs401681 are associated with bladder cancer risk in a Chinese population. Int J Mol Sci. 15:19330–19341. 2014. View Article : Google Scholar : PubMed/NCBI
2	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
3	Knowles MA: Molecular pathogenesis of bladder cancer. Int J Clin Oncol. 13:287–297. 2008. View Article : Google Scholar : PubMed/NCBI
4	Scélo G and Brennan P: The epidemiology of bladder and kidney cancer. Nat Clin Pract Urol. 4:205–217. 2007. View Article : Google Scholar : PubMed/NCBI
5	Wu D, Zhou Y, Pan H, Zhou J, Fan Y and Qu P: microRNA-99a inhibiting cell proliferation, migration and invasion by targeting fibroblast growth factor receptor 3 in bladder cancer. Oncol Lett. 7:1219–1224. 2014.PubMed/NCBI
6	Kim WJ and Bae SC: Molecular biomarkers in urothelial bladder cancer. Cancer Sci. 99:646–652. 2008. View Article : Google Scholar : PubMed/NCBI
7	Ambros V: MicroRNA pathways in flies and worms: Growth, death, fat, stress, and timing. Cell. 113:673–676. 2003. View Article : Google Scholar : PubMed/NCBI
8	Bartel DP: MicroRNAs: Target recognition and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
9	Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
10	Wu W, Sun M, Zou GM and Chen J: MicroRNA and cancer: Current status and prospective. Int J Cancer. 120:953–960. 2007. View Article : Google Scholar : PubMed/NCBI
11	Nelson KM and Weiss GJ: MicroRNAs and cancer: Past, present, and potential future. Mol Cancer Ther. 7:3655–3660. 2008. View Article : Google Scholar : PubMed/NCBI
12	Garzon R, Fabbri M, Cimmino A, Calin GA and Croce CM: MicroRNA expression and function in cancer. Trends Mol Med. 12:580–587. 2006. View Article : Google Scholar : PubMed/NCBI
13	Alvarez-Garcia I and Miska EA: MicroRNA functions in animal development and human disease. Development. 132:4653–4662. 2005. View Article : Google Scholar : PubMed/NCBI
14	Tana C, Giamberardino MA and Cipollone F: microRNA profiling in atherosclerosis, diabetes and migraine. Ann Med. 49:93–105. 2017. View Article : Google Scholar : PubMed/NCBI
15	Piletič K and Kunej T: MicroRNA epigenetic signatures in human disease. Arch Toxicol. 90:2405–2419. 2016. View Article : Google Scholar : PubMed/NCBI
16	Shang Y, Zang A, Li J, Jia Y, Li X, Zhang L, Huo R, Yang J, Feng J, Ge K, et al: MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner. Biomed Pharmacother. 83:1175–1181. 2016. View Article : Google Scholar : PubMed/NCBI
17	Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
18	Khan S, Brougham CL, Ryan J, Sahrudin A, O'Neill G, Wall D, Curran C, Newell J, Kerin MJ and Dwyer RM: miR-379 regulates cyclin B1 expression and is decreased in breast cancer. PLoS One. 8:e687532013. View Article : Google Scholar : PubMed/NCBI
19	Chen JS, Li HS, Huang JQ, Dong SH, Huang ZJ, Yi W, Zhan GF, Feng JT, Sun JC and Huang XH: MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma. Cancer Lett. 375:73–83. 2016. View Article : Google Scholar : PubMed/NCBI
20	Chen JS, Huang JQ, Dong SH and Huang XH: Effects of microRNA-379-5p on proliferation, migration and invasion of hepatocellular carcinoma cell line. Zhonghua Yi Xue Za Zhi. 96:1450–1453. 2016.(In Chinese). PubMed/NCBI
21	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2ΔΔC^T method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
22	Zhong XY, Yu JH, Zhang WG, Wang ZD, Dong Q, Tai S, Cui YF and Li H: MicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expression. Gene. 493:44–51. 2012. View Article : Google Scholar : PubMed/NCBI
23	Wu D, Niu X, Pan H, Zhou Y, Qu P and Zhou J: MicroRNA-335 is downregulated in bladder cancer and inhibits cell growth, migration and invasion via targeting ROCK1. Mol Med Rep. 13:4379–4385. 2016.PubMed/NCBI
24	Wang X, Liu Y, Liu X, Yang J, Teng G, Zhang L and Zhou C: MiR-124 inhibits cell proliferation, migration and invasion by directly targeting SOX9 in lung adenocarcinoma. Oncol Rep. 35:3115–3121. 2016.PubMed/NCBI
25	Baker M: RNA interference: MicroRNAs as biomarkers. Nature. 464:12272010. View Article : Google Scholar : PubMed/NCBI
26	Gururajan M, Josson S, Chu GC, Lu CL, Lu YT, Haga CL, Zhau HE, Liu C, Lichterman J, Duan P, et al: miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer. Clin Cancer Res. 20:6559–6569. 2014. View Article : Google Scholar : PubMed/NCBI
27	Osada H and Takahashi T: MicroRNAs in biological processes and carcinogenesis. Carcinogenesis. 28:2–12. 2007. View Article : Google Scholar : PubMed/NCBI
28	Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, Zhou W, Benson DM Jr, Hofmainster C, Alder H, et al: Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell. 18:349–351. 2016. View Article : Google Scholar
29	Marchetti A, Buttitta F, Girlando S, Palma P Dalla, Pellegrini S, Fina P, Doglioni C, Bevilacqua G and Barbareschi M: mdm2 gene alterations and mdm2 protein expression in breast carcinomas. J Pathol. 175:31–38. 1995. View Article : Google Scholar : PubMed/NCBI
30	Marchetti A, Buttitta F, Pellegrini S, Merlo G, Chella A, Angeletti CA and Bevilacqua G: mdm2 gene amplification and overexpression in non-small cell lung carcinomas with accumulation of the p53 protein in the absence of p53 gene mutations. Diagn Mol Pathol. 4:93–97. 1995. View Article : Google Scholar : PubMed/NCBI
31	Zhang C, Liu J, Wang X, Wu R, Lin M, Laddha SV, Yang Q, Chan CS and Feng Z: MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling. Oncotarget. 5:9106–9117. 2014. View Article : Google Scholar : PubMed/NCBI
32	Riou G, Barrois M, Prost S, Terrier MJ, Theodore C and Levine AJ: The p53 and mdm-2 genes in human testicular germ-cell tumors. Mol Carcinog. 12:124–131. 1995. View Article : Google Scholar : PubMed/NCBI
33	Lianes P, Orlow I, Zhang ZF, Oliva MR, Sarkis AS, Reuter VE and Cordon-Cardo C: Altered patterns of MDM2 and TP53 expression in human bladder cancer. J Natl Cancer Inst. 86:1325–1330. 1994. View Article : Google Scholar : PubMed/NCBI
34	Tuna B, Yörükoğlu K, Tüzel E, Güray M, Mungan U and Kirkali Z: Expression of p53 and mdm2 and their significance in recurrence of superficial bladder cancer. Pathol Res Pract. 199:323–328. 2003. View Article : Google Scholar : PubMed/NCBI
35	Schmitz-Dräger BJ, Kushima M, Goebell P, Jax TW, Gerharz CD, Bültel H, Schulz WA, Ebert T and Ackermann R: p53 and MDM2 in the development and progression of bladder cancer. Eur Urol. 32:487–493. 1997.PubMed/NCBI
36	Shiina H, Igawa M, Shigeno K, Yamasaki Y, Urakami S, Yoneda T, Wada Y, Honda S and Nagasaki M: Clinical significance of mdm2 and p53 expression in bladder cancer. A comparison with cell proliferation and apoptosis. Oncology. 56:239–247. 1999. View Article : Google Scholar : PubMed/NCBI